Latest On KalVista Pharmaceuticals, Inc (KALV):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-03-09 18:30 EST | News | KalVista Pharmaceticals GAAP EPS of -$0.75 beats by $0.26 | N/A |  |
| 2023-02-14 10:17 EST | News | KalVista stock rises on regulatory guidance for hereditary angioedema therapy | N/A | |
| 2023-01-25 18:21 EST | News | KalVista Pharmaceuticals: The Share Price Rally Requires An Adjustment Of My Investment Thesis | N/A | |
| 2022-12-27 23:34 EST | News | KalVista stock rises ~20% on $58M stock, warrants offering | N/A | |
| 2022-12-27 08:25 EST | News | KalVista stock dips on $58M stock, warrants offering | N/A | |
| 2022-12-09 20:24 EST | News | KalVista Pharmaceuticals GAAP EPS of -$0.90 beats by $0.16 | N/A | |
| 2022-12-08 09:31 EST | News | KalVista Pharmaceticals GAAP EPS of -$0.90 beats by $0.16 | N/A | |
| 2022-10-31 19:59 EST | News | KalVista's hereditary angioedema drug's orally disintegrating version shows promise in trial | N/A | |
| 2022-10-17 16:38 EST | News | KalVista Pharmaceuticals appoints Brian J.G. Pereira as Board Chairman | N/A | |
| 2022-10-14 19:01 EST | News | KalVista: Another Setback But The Key Value Driver Is Still In Place | N/A | |
| 2022-10-04 18:00 EST | News | KalVista stock slumps 37% as KVD824 trial for hereditary angioedema ended over liver safety concerns | N/A | |
| 2022-09-08 13:08 EST | News | KalVista Pharmaceticals GAAP EPS of -$0.94 | N/A | |
| 2022-08-23 05:02 EST | News | KalVista reaches five-month high as rival tumbles on hereditary angioedema | N/A | |
| 2022-07-07 14:49 EST | News | KalVista Pharmaceticals GAAP EPS of -$0.98 beats by $0.11 | N/A | |
| 2022-03-10 17:54 EST | News | KalVista Pharmaceticals GAAP EPS of -$0.92 in-line | N/A | |
| 2022-03-07 21:49 EST | News | KalVista begins phase 3 trial of oral drug KVD900 to treat hereditary angioedema attacks | N/A | |
| 2022-01-04 14:36 EST | News | KalVista Pharmaceuticals grants inducement options to four new employees | N/A | |
| 2021-12-14 16:42 EST | News | Warning: KALV is at high risk of performing badly | N/A | |
| 2021-12-03 16:14 EST | News | KalVista Pharmaceuticals reports inducement grants to 6 new employees | N/A | |
| 2021-11-24 00:36 EST | News | Kalvista Pharmaceuticals (KALV) Investor Presentation - Slideshow | N/A | |
| 2021-11-10 10:35 EST | News | KalVista to begin dosing in late-stage hereditary angioedema study early next year | N/A | |
| 2021-09-27 20:18 EST | News | Warning: KALV has been downgraded to Very Bearish | N/A | |
| 2021-09-23 06:04 EST | News | Warning: KALV has been downgraded to Very Bearish. | N/A | |
| 2021-09-21 22:18 EST | News | KalVista announces lifting of clinical hold placed on hereditary angioedema study | N/A | |
| 2021-09-09 06:47 EST | News | KalVista Pharmaceticals EPS beats by $0.06 | N/A | |
| 2021-07-21 13:37 EST | News | KalVista Pharmaceuticals files for $300M mixed shelf offering | N/A | |
| 2021-07-21 13:29 EST | News | KalVista Pharma's oral KVD900 shows rapid improvement in HAE attacks in mid-stage study | N/A | |
| 2021-07-21 13:15 EST | News | KalVista and BioCryst fall after Intellia shows promise in gene editing | N/A | |
| 2021-07-21 13:14 EST | News | KalVista favored at Cantor despite emerging threat from Intellia | N/A | |
| 2021-07-21 13:13 EST | News | KalVista, BioCryst's rough week continues as shares down again | N/A | |
| 2021-07-21 13:08 EST | News | KalVista Pharma's KVD900 slows progression, accelerates resolution of attacks in HAE patients | N/A | |
| 2021-07-21 13:07 EST | News | KalVista Pharmaceticals EPS misses by $0.10 | N/A | |
| 2021-05-04 00:57 EST | News | KalVista Pharmaceuticals names new medical chief | N/A | |
| 2021-04-20 07:11 EST | News | FDA puts clinical hold on KalVista Pharma's mid-stage KVD824 trial | N/A | |
| 2021-03-16 21:12 EST | Analyst Rating | The Analyst Target Price has decreased from $55.71 to $55.43. | Neutral | |
| 2021-03-12 07:58 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-12 04:01 EST | Earnings Estimate | An EPS average of -$0.69 is estimated for the quarter ending on July 31, 2021. | Sell | |
| 2021-03-11 09:15 EST | News | KalVista Pharmaceticals EPS beats by $0.04 | N/A | |
| 2021-02-18 04:08 EST | Analyst Rating | The Analyst Target Price has increased from $46.43 to $55.71. | Buy | |
| 2021-02-17 11:44 EST | Analyst Rating | The Analyst Target Price has increased from $42.43 to $46.43. | Buy | |
| 2021-02-17 05:19 EST | News | KalVista Pharmaceuticals closes $222.5M capital raise | N/A | |
| 2021-02-11 11:51 EST | Analyst Rating | The Analyst Target Price has increased from $39.86 to $42.43. | Buy | |
| 2021-02-11 08:37 EST | News | KalVista Pharma secures $193.5M via equity offering; shares up 6% | N/A | |
| 2021-02-10 13:45 EST | News | TLRY, GLUU, ABEO and TYME among premarket gainers | N/A | |
| 2021-02-10 13:45 EST | News | KalVista stock catapults on positive mid-stage KVD900 trial data | N/A | |
| 2021-02-10 13:44 EST | News | KalVista announces proposed 4.5M public offering | N/A | |
| 2021-02-10 13:44 EST | News | KalVista extends gains as Jefferies raise price target on positive angioedema data | N/A | |
| 2021-02-10 11:52 EST | Analyst Rating | The Analyst Target Price has increased from $30.86 to $39.86. | Neutral | |
| 2021-01-27 12:02 EST | Analyst Rating | The Analyst Target Price has increased from $29.86 to $30.86. | Buy | |
| 2021-01-06 15:58 EST | Financials | Company financials have been released. | Neutral | |
About KalVista Pharmaceuticals, Inc (KALV):
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; KVD900, which is in Phase II clinical trial for treating HAE attacks; and KVD824, an oral plasma kallikrein inhibitor that completed a Phase I clinical trial for treating DME or HAE. The company is headquartered in Cambridge, Massachusetts.
General
- Name KalVista Pharmaceuticals, Inc
- Symbol KALV
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 56
- Last Split Factor1:14
- Last Split Date2016-11-22
- Fiscal Year EndApril
- IPO Date2015-04-09
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.kalvista.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 152.05
- Price/Book (Most Recent Quarter) 13.49
- Enterprise Value Revenue 137.27
View More
Financials
- Most Recent Quarter 2021-01-31
- Current Year EPS Estimate -$2.27
- Next Year EPS Estimate -$2.86
- Operating Margin -1277%
- Return on Assets -36%
- Return on Equity -51%
- Revenue 3.82 million
- Earnings Per Share -$1.38
- Revenue Per Share $0.21
- Gross Profit -27504000
- Quarterly Earnings Growth 30.7%
View More
Highlights
- Market Capitalization 868.78 million
- EBITDA -31926000
- PE Ratio -15.23
- Analyst Target Price $55.43
- Book Value Per Share $3.25
View More
Share Statistics
- Shares Outstanding 24.12 million
- Shares Float 21.27 million
- % Held by Insiders 906%
- % Held by Institutions 96.23%
- Shares Short 782353
- Shares Short Prior Month 641079
- Short Ratio 0.34
- Short % of Float 4%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 2.17
- 52 Week High $43.08
- 52 Week Low $5.63
- 50 Day Moving Average 29.76
- 200 Day Moving Average 19.69
View More
Dividends
- Dividend Date 2016-11-22
- ExDividend Date N/A
- Dividend Yield 0%
View More
KalVista Pharmaceuticals, Inc (KALV) Dividend Calendar:
KALV's last dividend payment was made to shareholders on November 22, 2016.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
KalVista Pharmaceuticals, Inc (KALV) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2021-01-31 | 2021-03-11 | $N/A | -$0.56 | -$0.59 | 5.08% |
| 2020-10-31 | 2020-12-10 | $N/A | -$0.58 | -$0.66 | 12.12% |
| 2020-07-31 | 2020-09-14 | $N/A | -$0.61 | -$0.55 | -11.93% |
| 2020-04-30 | 2020-06-29 | $3.82 million | -$0.37 | -$0.61 | 39.34% |
| 2020-01-31 | 2020-03-10 | $1.58 million | -$0.52 | -$0.52 | 0% |
| 2019-10-31 | 2019-12-03 | $N/A | -$0.33 | -$0.54 | 38.51% |
| 2019-07-31 | 2019-09-09 | $3.37 million | -$0.42 | -$0.59 | 28.21% |
| 2019-04-30 | 2019-07-15 | $2.93 million | -$0.49 | -$0.35 | -39.01% |
| 2019-01-31 | 2019-03-14 | $3.89 million | -$0.23 | -$0.46 | 50.36% |
| 2018-10-31 | 2018-12-14 | $5.59 million | -$0.22 | -$0.42 | 47.93% |
| 2018-07-31 | 2018-09-14 | $3.72 million | -$0.47 | -$0.33 | -42.42% |
| 2018-04-30 | 2018-07-30 | $4.84 million | -$0.04 | -$0.35 | 88.57% |
| 2018-01-31 | 2018-03-16 | $2.33 million | -$0.49 | -$0.13 | -276.92% |
| 2017-10-31 | 2017-12-14 | $1.13 million | -$0.50 | -$0.45 | -11.11% |
| 2017-07-31 | 2017-09-14 | $96000 | -$0.51 | -$0.59 | 13.56% |
| 2017-04-30 | 2017-07-27 | $1.24 million | -$0.43 | ||
| 2017-01-31 | 2017-03-16 | $248000 | -$1.03 | ||
| 2016-07-31 | 2016-08-12 | $945000 | -$3.92 | -$3.50 | -12% |
| 2016-04-30 | 2016-05-12 | $2.13 million | -$3.50 | -$2.59 | -35.14% |
| 2016-01-31 | 2016-03-30 | $7000 | -$3.21 | -$3.36 | 4.46% |
| 2015-10-31 | 2015-11-11 | $8000 | -$2.66 | -$3.60 | 26.11% |
| 2015-07-31 | 2015-08-11 | $7000 | -$5.18 | -$2.89 | -79.24% |
| 2015-04-30 | 2015-05-15 | $7000 | -$103.32 | -$2.33 | -4334.33% |
KalVista Pharmaceuticals, Inc (KALV) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
KalVista Pharmaceuticals, Inc (KALV) Chart:
KalVista Pharmaceuticals, Inc (KALV) News:
Below you will find a list of latest news for KalVista Pharmaceuticals, Inc (KALV) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
KalVista Pharmaceuticals, Inc (KALV) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | 2.5 | 0 | CALL | 0 | 0 | 656.83 | TRUE | 0 | 0 |
| 2025-09-19 | 5 | 9.2 | CALL | 0 | 1 | 374.16 | TRUE | 0 | 0 |
| 2025-09-19 | 7.5 | 4.8 | CALL | 0 | 7 | 260.73 | TRUE | 0 | 0 |
| 2025-09-19 | 10 | 2.84 | CALL | 0 | 129 | 165.05 | TRUE | 0 | 0 |
| 2025-09-19 | 12.5 | 0.9 | CALL | 0 | 657 | 48.66 | TRUE | 0 | 0 |
| 2025-09-19 | 15 | 0.5 | CALL | 0 | 1505 | 104.43 | FALSE | 0 | 0 |
| 2025-09-19 | 17.5 | 0.35 | CALL | 0 | 1151 | 98.25 | FALSE | 0 | 0 |
| 2025-09-19 | 20 | 0.15 | CALL | 0 | 142 | 138.7 | FALSE | 0 | 0 |
| 2025-09-19 | 22.5 | 0.1 | CALL | 0 | 28 | 206.63 | FALSE | 0 | 0 |
| 2025-09-19 | 25 | 0.1 | CALL | 0 | 28 | 344.94 | FALSE | 0 | 0 |
| 2025-09-19 | 30 | 0 | CALL | 0 | 0 | 218.82 | FALSE | 0 | 0 |
| 2025-09-19 | 2.5 | 0 | PUT | 0 | 0 | 527.05 | FALSE | 0 | 0 |
| 2025-09-19 | 5 | 0 | PUT | 0 | 0 | 682.92 | FALSE | 0 | 0 |
| 2025-09-19 | 7.5 | 0.8 | PUT | 0 | 203 | 200.44 | FALSE | 0 | 0 |
| 2025-09-19 | 10 | 0.2 | PUT | 0 | 226 | 93.47 | FALSE | 0 | 0 |
| 2025-09-19 | 12.5 | 0.75 | PUT | 0 | 330 | 50.55 | FALSE | 0 | 0 |
| 2025-09-19 | 15 | 2.8 | PUT | 0 | 53 | 173.02 | TRUE | 0 | 0 |
| 2025-09-19 | 17.5 | 2.95 | PUT | 0 | 28 | 135.38 | TRUE | 0 | 0 |
| 2025-09-19 | 20 | 0 | PUT | 0 | 0 | 190.72 | TRUE | 0 | 0 |
| 2025-09-19 | 22.5 | 0 | PUT | 0 | 0 | 208.34 | TRUE | 0 | 0 |
| 2025-09-19 | 25 | 0 | PUT | 0 | 0 | 216.61 | TRUE | 0 | 0 |
| 2025-09-19 | 30 | 0 | PUT | 0 | 0 | 246.61 | TRUE | 0 | 0 |
| 2025-10-17 | 2.5 | 0 | CALL | 0 | 0 | 730.62 | TRUE | 0 | 0 |
| 2025-10-17 | 5 | 0 | CALL | 0 | 0 | 272.15 | TRUE | 0 | 0 |
| 2025-10-17 | 7.5 | 0 | CALL | 0 | 0 | 184.39 | TRUE | 0 | 0 |
| 2025-10-17 | 10 | 0 | CALL | 0 | 0 | 111.09 | TRUE | 0 | 0 |
| 2025-10-17 | 12.5 | 0 | CALL | 0 | 0 | 78.39 | TRUE | 0 | 0 |
| 2025-10-17 | 15 | 0.8 | CALL | 0 | 313 | 87.76 | FALSE | 0 | 0 |
| 2025-10-17 | 17.5 | 0 | CALL | 0 | 0 | 67.64 | FALSE | 0 | 0 |
| 2025-10-17 | 20 | 0.15 | CALL | 0 | 2 | 137.4 | FALSE | 0 | 0 |
| 2025-10-17 | 22.5 | 0.2 | CALL | 0 | 9 | 118.63 | FALSE | 0 | 0 |
| 2025-10-17 | 25 | 0 | CALL | 0 | 0 | 132.69 | FALSE | 0 | 0 |
| 2025-10-17 | 2.5 | 0 | PUT | 0 | 0 | 376.71 | FALSE | 0 | 0 |
| 2025-10-17 | 5 | 0 | PUT | 0 | 0 | 224.33 | FALSE | 0 | 0 |
| 2025-10-17 | 7.5 | 0 | PUT | 0 | 0 | 143.6 | FALSE | 0 | 0 |
| 2025-10-17 | 10 | 0 | PUT | 0 | 0 | 171.74 | FALSE | 0 | 0 |
| 2025-10-17 | 12.5 | 1.3 | PUT | 0 | 5030 | 76.67 | FALSE | 0 | 0 |
| 2025-10-17 | 15 | 0 | PUT | 0 | 0 | 32.63 | TRUE | 0 | 0 |
| 2025-10-17 | 17.5 | 0 | PUT | 0 | 0 | 125.97 | TRUE | 0 | 0 |
| 2025-10-17 | 20 | 0 | PUT | 0 | 0 | 138.51 | TRUE | 0 | 0 |
| 2025-10-17 | 22.5 | 0 | PUT | 0 | 0 | 94.26 | TRUE | 0 | 0 |
| 2025-10-17 | 25 | 0 | PUT | 0 | 0 | 100.07 | TRUE | 0 | 0 |
| 2025-12-19 | 2.5 | 0 | CALL | 0 | 0 | 215.68 | TRUE | 0 | 0 |
| 2025-12-19 | 5 | 10.6 | CALL | 0 | 1 | 190.12 | TRUE | 0 | 0 |
| 2025-12-19 | 7.5 | 8.37 | CALL | 0 | 5 | 68.94 | TRUE | 0 | 0 |
| 2025-12-19 | 10 | 4.1 | CALL | 0 | 4150 | 86.16 | TRUE | 0 | 0 |
| 2025-12-19 | 12.5 | 2.39 | CALL | 1 | 34 | 71.62 | TRUE | 2.39 | 0 |
| 2025-12-19 | 15 | 1.75 | CALL | 0 | 256 | 83.24 | FALSE | 0 | 0 |
| 2025-12-19 | 17.5 | 0.69 | CALL | 1 | 38 | 64.53 | FALSE | 0.69 | 0 |
| 2025-12-19 | 20 | 0.65 | CALL | 0 | 26 | 102.35 | FALSE | 0 | 0 |
| 2025-12-19 | 22.5 | 0 | CALL | 0 | 0 | 89.58 | FALSE | 0 | 0 |
| 2025-12-19 | 25 | 0.4 | CALL | 0 | 28 | 93.45 | FALSE | 0 | 0 |
| 2025-12-19 | 30 | 0.65 | CALL | 0 | 7 | 108.1 | FALSE | 0 | 0 |
| 2025-12-19 | 2.5 | 0 | PUT | 0 | 0 | 214.44 | FALSE | 0 | 0 |
| 2025-12-19 | 5 | 0 | PUT | 0 | 0 | 155.53 | FALSE | 0 | 0 |
| 2025-12-19 | 7.5 | 0.57 | PUT | 0 | 0 | 130.39 | FALSE | 0 | 0 |
| 2025-12-19 | 10 | 1.15 | PUT | 0 | 16 | 146.25 | FALSE | 0 | 0 |
| 2025-12-19 | 12.5 | 2.05 | PUT | 0 | 15 | 58.61 | FALSE | 0 | 0 |
| 2025-12-19 | 15 | 3.16 | PUT | 0 | 165 | 63.4 | TRUE | 0 | 0 |
| 2025-12-19 | 17.5 | 4.1 | PUT | 0 | 4 | 85.85 | TRUE | 0 | 0 |
| 2025-12-19 | 20 | 0 | PUT | 0 | 0 | 54.59 | TRUE | 0 | 0 |
| 2025-12-19 | 22.5 | 0 | PUT | 0 | 0 | 97.67 | TRUE | 0 | 0 |
| 2025-12-19 | 25 | 0 | PUT | 0 | 0 | 93.59 | TRUE | 0 | 0 |
| 2025-12-19 | 30 | 0 | PUT | 0 | 0 | 104.62 | TRUE | 0 | 0 |
| 2026-03-20 | 2.5 | 0 | CALL | 0 | 0 | 212.95 | TRUE | 0 | 0 |
| 2026-03-20 | 5 | 8 | CALL | 0 | 2 | 133.86 | TRUE | 0 | 0 |
| 2026-03-20 | 7.5 | 0 | CALL | 0 | 0 | 84.02 | TRUE | 0 | 0 |
| 2026-03-20 | 10 | 4.35 | CALL | 0 | 5 | 75.16 | TRUE | 0 | 0 |
| 2026-03-20 | 12.5 | 2.89 | CALL | 0 | 1 | 54.8 | TRUE | 0 | 0 |
| 2026-03-20 | 15 | 1.51 | CALL | 0 | 1 | 57.85 | FALSE | 0 | 0 |
| 2026-03-20 | 17.5 | 2 | CALL | 0 | 29 | 65.58 | FALSE | 0 | 0 |
| 2026-03-20 | 20 | 0 | CALL | 0 | 0 | 95.7 | FALSE | 0 | 0 |
| 2026-03-20 | 22.5 | 1.25 | CALL | 0 | 2 | 93.85 | FALSE | 0 | 0 |
| 2026-03-20 | 25 | 0 | CALL | 0 | 0 | 93.7 | FALSE | 0 | 0 |
| 2026-03-20 | 30 | 0.71 | CALL | 0 | 7 | 92.45 | FALSE | 0 | 0 |
| 2026-03-20 | 2.5 | 0 | PUT | 0 | 0 | 767.97 | FALSE | 0 | 0 |
| 2026-03-20 | 5 | 0 | PUT | 0 | 0 | 257.5 | FALSE | 0 | 0 |
| 2026-03-20 | 7.5 | 0 | PUT | 0 | 0 | 90.81 | FALSE | 0 | 0 |
| 2026-03-20 | 10 | 1.25 | PUT | 0 | 3 | 91.56 | FALSE | 0 | 0 |
| 2026-03-20 | 12.5 | 0 | PUT | 0 | 0 | 65.09 | FALSE | 0 | 0 |
| 2026-03-20 | 15 | 3.9 | PUT | 0 | 1 | 81.16 | TRUE | 0 | 0 |
| 2026-03-20 | 17.5 | 0 | PUT | 0 | 0 | 84.33 | TRUE | 0 | 0 |
| 2026-03-20 | 20 | 0 | PUT | 0 | 0 | 93.79 | TRUE | 0 | 0 |
| 2026-03-20 | 22.5 | 0 | PUT | 0 | 0 | 86.56 | TRUE | 0 | 0 |
| 2026-03-20 | 25 | 0 | PUT | 0 | 0 | 114.15 | TRUE | 0 | 0 |
| 2026-03-20 | 30 | 0 | PUT | 0 | 0 | 81.43 | TRUE | 0 | 0 |
Latest KALV Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 2 | $8.17 |
| Jun 13, 2022 7:59 PM EST | 2 | $8.17 |
| Jun 13, 2022 7:59 PM EST | 100 | $8.18 |
| Jun 13, 2022 7:59 PM EST | 5 | $8.18 |
| Jun 13, 2022 7:59 PM EST | 2 | $8.18 |
KalVista Pharmaceuticals, Inc (KALV) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459020031523/0001564590-20-031523-index.htm |
| 2018-12-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1348911/000000000018038823/0000000000-18-038823-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1348911/000031506620001058/0000315066-20-001058-index.htm |
| 2020-04-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1348911/000031506620001437/0000315066-20-001437-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000089924318031591/0000899243-18-031591-index.htm |
| 2019-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm |
| 2019-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000089924319008526/0000899243-19-008526-index.htm |
| 2019-03-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm |
| 2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1348911/000110465920021718/0001104659-20-021718-index.htm |
| 2019-04-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1348911/000114420419019693/0001144204-19-019693-index.htm |
| 2019-04-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1348911/000114420419020958/0001144204-19-020958-index.htm |
| 2018-12-14 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1348911/000119312518350025/0001193125-18-350025-index.htm |
| 2018-12-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1348911/000119312518354546/0001193125-18-354546-index.htm |
| 2019-02-26 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1348911/000119312519050840/0001193125-19-050840-index.htm |
| 2019-03-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1348911/000119312519080883/0001193125-19-080883-index.htm |
| 2019-03-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1348911/000119312519092927/0001193125-19-092927-index.htm |
| 2019-03-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000119312519092945/0001193125-19-092945-index.htm |
| 2019-04-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1348911/000119312519096580/0001193125-19-096580-index.htm |
| 2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000119312519261630/0001193125-19-261630-index.htm |
| 2020-03-23 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1348911/000119312520082504/0001193125-20-082504-index.htm |
| 2020-08-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1348911/000119312520229923/0001193125-20-229923-index.htm |
| 2019-04-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1348911/000119380519000378/0001193805-19-000378-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1348911/000119380520000199/0001193805-20-000199-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120053393/0001209191-20-053393-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120053394/0001209191-20-053394-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120053395/0001209191-20-053395-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120053396/0001209191-20-053396-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120053397/0001209191-20-053397-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120053398/0001209191-20-053398-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120053399/0001209191-20-053399-index.htm |
| 2020-10-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055362/0001209191-20-055362-index.htm |
| 2020-10-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055363/0001209191-20-055363-index.htm |
| 2020-10-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055365/0001209191-20-055365-index.htm |
| 2020-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm |
| 2020-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm |
| 2020-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm |
| 2020-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120056468/0001209191-20-056468-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120056790/0001209191-20-056790-index.htm |
| 2020-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000120919120056919/0001209191-20-056919-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1348911/000121390020003600/0001213900-20-003600-index.htm |
| 2018-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459018023592/0001564590-18-023592-index.htm |
| 2018-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459018023967/0001564590-18-023967-index.htm |
| 2018-12-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459018030918/0001564590-18-030918-index.htm |
| 2018-12-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1348911/000156459018030939/0001564590-18-030939-index.htm |
| 2019-02-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459019001698/0001564590-19-001698-index.htm |
| 2019-03-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1348911/000156459019007827/0001564590-19-007827-index.htm |
| 2019-03-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1348911/000156459019007847/0001564590-19-007847-index.htm |
| 2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459019007850/0001564590-19-007850-index.htm |
| 2019-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459019012737/0001564590-19-012737-index.htm |
| 2019-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459019024241/0001564590-19-024241-index.htm |
| 2019-07-16 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/1348911/000156459019025007/0001564590-19-025007-index.htm |
| 2019-07-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1348911/000156459019025009/0001564590-19-025009-index.htm |
| 2019-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459019025066/0001564590-19-025066-index.htm |
| 2019-08-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1348911/000156459019032858/0001564590-19-032858-index.htm |
| 2019-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459019034361/0001564590-19-034361-index.htm |
| 2019-09-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1348911/000156459019034364/0001564590-19-034364-index.htm |
| 2019-12-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1348911/000156459019045155/0001564590-19-045155-index.htm |
| 2019-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459019045159/0001564590-19-045159-index.htm |
| 2020-03-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1348911/000156459020009752/0001564590-20-009752-index.htm |
| 2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459020009764/0001564590-20-009764-index.htm |
| 2020-03-10 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1348911/000156459020009778/0001564590-20-009778-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459020029018/0001564590-20-029018-index.htm |
| 2020-07-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1348911/000156459020031501/0001564590-20-031501-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459020031523/0001564590-20-031523-index.htm |
| 2020-09-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1348911/000156459020043418/0001564590-20-043418-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459020043423/0001564590-20-043423-index.htm |
| 2020-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1348911/000156459020045741/0001564590-20-045741-index.htm |
| 2018-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761918002982/0001567619-18-002982-index.htm |
| 2018-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761918002983/0001567619-18-002983-index.htm |
| 2018-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761918002984/0001567619-18-002984-index.htm |
| 2018-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761918002985/0001567619-18-002985-index.htm |
| 2018-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761918003781/0001567619-18-003781-index.htm |
| 2018-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761918003782/0001567619-18-003782-index.htm |
| 2018-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761918003783/0001567619-18-003783-index.htm |
| 2018-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761918003784/0001567619-18-003784-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001252/0001567619-19-001252-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001375/0001567619-19-001375-index.htm |
| 2019-01-24 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001608/0001567619-19-001608-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm |
| 2019-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001860/0001567619-19-001860-index.htm |
| 2019-02-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919002401/0001567619-19-002401-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919002402/0001567619-19-002402-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919007013/0001567619-19-007013-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919008626/0001567619-19-008626-index.htm |
| 2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919008965/0001567619-19-008965-index.htm |
| 2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm |
| 2019-04-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009058/0001567619-19-009058-index.htm |
| 2019-04-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009059/0001567619-19-009059-index.htm |
| 2019-04-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009060/0001567619-19-009060-index.htm |
| 2019-04-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009061/0001567619-19-009061-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919011569/0001567619-19-011569-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919011575/0001567619-19-011575-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919011577/0001567619-19-011577-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919011579/0001567619-19-011579-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919011583/0001567619-19-011583-index.htm |
| 2019-06-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919012846/0001567619-19-012846-index.htm |
| 2019-06-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919014121/0001567619-19-014121-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919014122/0001567619-19-014122-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919014946/0001567619-19-014946-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015141/0001567619-19-015141-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015142/0001567619-19-015142-index.htm |
| 2019-07-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm |
| 2019-09-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919018888/0001567619-19-018888-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919019233/0001567619-19-019233-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919019234/0001567619-19-019234-index.htm |
| 2019-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919019235/0001567619-19-019235-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023162/0001567619-19-023162-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023611/0001567619-19-023611-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023612/0001567619-19-023612-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761920002452/0001567619-20-002452-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761920002453/0001567619-20-002453-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000156761920002454/0001567619-20-002454-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1348911/000158064219000781/0001580642-19-000781-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1348911/000158064220000514/0001580642-20-000514-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1348911/000160226419000001/0001602264-19-000001-index.htm |
| 2018-12-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1348911/999999999518003215/9999999995-18-003215-index.htm |
KalVista Pharmaceuticals, Inc (KALV) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of KalVista Pharmaceuticals, Inc (KALV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 906%Institutional Ownership: 9623%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-04-05 | Andreas Maetzel | Senior Vice President Medical | Sell | 5,000.00 | 30.00 | 150,011.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919008626/0001567619-19-008626-index.htm |
| 2019-09-27 | DANIEL B SOLAND | Director | Buy | 7,962.00 | 11.87 | 94,497.79 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919018888/0001567619-19-018888-index.htm |
| 2019-04-17 | Edward P. Feener | Chief Scientific Officer | Sell | 916.00 | 25.39 | 23,260.17 | 100,034.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919008965/0001567619-19-008965-index.htm |
| 2019-04-17 | Edward P. Feener | Chief Scientific Officer | Sell | 3,084.00 | 24.78 | 76,406.10 | 100,950.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919008965/0001567619-19-008965-index.htm |
| 2019-07-29 | Albert Cha | Director | Buy | 24,730.00 | 17.13 | 423,691.67 | 1,022,493.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm |
| 2019-01-16 | Edward P. Feener | Chief Scientific Officer | Sell | 2,300.00 | 19.81 | 45,572.43 | 104,034.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001375/0001567619-19-001375-index.htm |
| 2019-07-17 | Albert Cha | Director | Buy | 220.00 | 16.93 | 3,724.01 | 104,551.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm |
| 2019-01-16 | Edward P. Feener | Chief Scientific Officer | Sell | 1,700.00 | 19.20 | 32,637.45 | 106,334.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001375/0001567619-19-001375-index.htm |
| 2020-10-30 | Albert Cha | Director | Buy | 68,255.00 | 17.17 | 1,171,808.67 | 1,090,748.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120056790/0001209191-20-056790-index.htm |
| 2018-09-18 | Edward P. Feener | Chief Scientific Officer | Buy | 12,500.00 | 110,534.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761918002984/0001567619-18-002984-index.htm | ||
| 2020-10-30 | Albert Cha | Director | Buy | 47,431.00 | 17.34 | 822,259.07 | 1,138,179.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120056790/0001209191-20-056790-index.htm |
| 2019-07-19 | Albert Cha | Director | Buy | 10,320.00 | 17.68 | 182,453.47 | 114,871.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm |
| 2019-07-26 | Albert Cha | Director | Buy | 4,558.00 | 16.83 | 76,717.98 | 119,429.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm |
| 2019-07-29 | Albert Cha | Director | Buy | 5,137.00 | 17.13 | 88,010.68 | 124,566.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm |
| 2019-03-18 | Venrock Healthcare Capital Partners II, L.P. | 10% Share Holder | Sell | 500,000.00 | 28.75 | 14,375,000.00 | 1,544,112.00 | https://www.sec.gov/Archives/edgar/data/1348911/000160226419000001/0001602264-19-000001-index.htm |
| 2019-04-10 | SVLSF IV, LLC | 10% Share Holder | Sell | 13,157.00 | 29.40 | 386,752.65 | 1,672,105.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm |
| 2019-04-09 | SVLSF IV, LLC | 10% Share Holder | Sell | 13,292.00 | 28.53 | 379,227.41 | 1,685,262.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm |
| 2019-04-08 | SVLSF IV, LLC | 10% Share Holder | Sell | 22,171.00 | 29.49 | 653,864.91 | 1,698,554.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm |
| 2019-04-02 | SVLSF IV, LLC | 10% Share Holder | Sell | 8,888.00 | 28.76 | 255,652.65 | 1,720,725.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm |
| 2019-04-01 | SVLSF IV, LLC | 10% Share Holder | Sell | 51,373.00 | 27.66 | 1,420,884.71 | 1,729,613.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm |
| 2019-03-29 | SVLSF IV, LLC | 10% Share Holder | Sell | 34,133.00 | 28.40 | 969,240.67 | 1,780,986.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm |
| 2019-03-28 | SVLSF IV, LLC | 10% Share Holder | Sell | 35,653.00 | 27.80 | 991,189.05 | 1,815,119.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm |
| 2019-03-27 | SVLSF IV, LLC | 10% Share Holder | Sell | 56,318.00 | 29.06 | 1,636,556.03 | 1,850,772.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm |
| 2019-03-26 | SVLSF IV, LLC | 10% Share Holder | Sell | 29,262.00 | 29.70 | 869,008.25 | 1,907,090.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm |
| 2019-03-18 | SVLSF IV, LLC | 10% Share Holder | Sell | 255,224.00 | 26.70 | 6,814,480.80 | 1,936,352.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319008526/0000899243-19-008526-index.htm |
| 2020-10-21 | Thomas Andrew Crockett | CEO | Sell | 3,693.00 | 19.01 | 70,193.59 | 195,420.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm |
| 2020-10-21 | Thomas Andrew Crockett | CEO | Sell | 13,052.00 | 18.51 | 241,640.81 | 199,113.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm |
| 2019-09-26 | DANIEL B SOLAND | Director | Buy | 2,038.00 | 11.90 | 24,252.20 | 2,038.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919018888/0001567619-19-018888-index.htm |
| 2020-10-21 | Thomas Andrew Crockett | CEO | Sell | 5,800.00 | 17.48 | 101,412.42 | 212,165.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm |
| 2020-10-20 | Thomas Andrew Crockett | CEO | Sell | 4,776.00 | 18.01 | 85,991.88 | 217,965.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm |
| 2019-03-05 | SVLSF IV, LLC | 10% Share Holder | Sell | 31,439.00 | 23.04 | 724,244.52 | 2,191,576.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm |
| 2019-03-04 | SVLSF IV, LLC | 10% Share Holder | Sell | 42,181.00 | 22.91 | 966,240.17 | 2,223,015.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm |
| 2020-10-20 | Thomas Andrew Crockett | CEO | Sell | 11,218.00 | 17.27 | 193,786.46 | 222,741.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055588/0001209191-20-055588-index.htm |
| 2019-02-21 | SVLSF IV, LLC | 10% Share Holder | Sell | 167,779.00 | 20.60 | 3,456,247.40 | 2,265,196.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm |
| 2020-10-16 | Thomas Andrew Crockett | CEO | Sell | 1,261.00 | 17.01 | 21,444.06 | 236,959.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055362/0001209191-20-055362-index.htm |
| 2020-02-05 | Thomas Andrew Crockett | CEO | Sell | 200.00 | 17.05 | 3,410.00 | 238,220.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761920002452/0001567619-20-002452-index.htm |
| 2019-12-20 | Thomas Andrew Crockett | CEO | Sell | 2,300.00 | 17.02 | 39,150.37 | 238,420.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023611/0001567619-19-023611-index.htm |
| 2019-12-16 | Thomas Andrew Crockett | CEO | Sell | 5,400.00 | 17.06 | 92,115.90 | 240,720.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023162/0001567619-19-023162-index.htm |
| 2019-02-20 | SVLSF IV, LLC | 10% Share Holder | Sell | 22,594.00 | 20.02 | 452,239.24 | 2,432,975.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm |
| 2019-02-19 | SVLSF IV, LLC | 10% Share Holder | Sell | 17,912.00 | 20.73 | 371,365.91 | 2,455,569.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm |
| 2019-12-13 | Thomas Andrew Crockett | CEO | Sell | 2,200.00 | 17.06 | 37,536.40 | 246,120.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023162/0001567619-19-023162-index.htm |
| 2019-01-07 | SVLSF IV, LLC | 10% Share Holder | Sell | 2,527.00 | 20.41 | 51,581.12 | 2,473,481.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm |
| 2019-01-03 | SVLSF IV, LLC | 10% Share Holder | Sell | 1,653.00 | 20.01 | 33,081.49 | 2,476,008.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm |
| 2019-01-02 | SVLSF IV, LLC | 10% Share Holder | Sell | 194.00 | 20.00 | 3,880.00 | 2,477,661.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm |
| 2018-12-31 | SVLSF IV, LLC | 10% Share Holder | Sell | 24,716.00 | 20.00 | 494,418.86 | 2,477,855.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm |
| 2019-12-12 | Thomas Andrew Crockett | CEO | Sell | 100.00 | 17.00 | 1,700.00 | 248,320.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023162/0001567619-19-023162-index.htm |
| 2019-07-15 | Thomas Andrew Crockett | CEO | Sell | 10,000.00 | 17.04 | 170,407.00 | 248,510.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919014946/0001567619-19-014946-index.htm |
| 2018-12-28 | SVLSF IV, LLC | 10% Share Holder | Sell | 3,631.00 | 20.03 | 72,718.04 | 2,502,571.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm |
| 2018-12-19 | SVLSF IV, LLC | 10% Share Holder | Sell | 2,077.00 | 20.02 | 41,577.39 | 2,506,202.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924318031591/0000899243-18-031591-index.htm |
| 2019-04-15 | Thomas Andrew Crockett | CEO | Sell | 300.00 | 25.92 | 7,776.99 | 258,510.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009060/0001567619-19-009060-index.htm |
| 2019-04-15 | Thomas Andrew Crockett | CEO | Sell | 9,700.00 | 24.76 | 240,180.73 | 258,810.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009060/0001567619-19-009060-index.htm |
| 2019-03-14 | Thomas Andrew Crockett | CEO | Sell | 3,000.00 | 30.16 | 90,483.90 | 268,510.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919007013/0001567619-19-007013-index.htm |
| 2019-01-14 | Thomas Andrew Crockett | CEO | Sell | 901.00 | 19.86 | 17,895.93 | 271,510.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001252/0001567619-19-001252-index.htm |
| 2019-01-14 | Thomas Andrew Crockett | CEO | Sell | 9,099.00 | 19.28 | 175,432.36 | 272,411.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001252/0001567619-19-001252-index.htm |
| 2018-09-18 | Benjamin L Palleiko | CFO and Secretary | Buy | 32,500.00 | 32,500.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761918002982/0001567619-18-002982-index.htm | ||
| 2019-04-18 | Benjamin L Palleiko | CBO, CFO and Secretary | Sell | 1,073.00 | 25.51 | 27,373.41 | 32,500.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm |
| 2019-04-22 | Benjamin L Palleiko | CBO, CFO and Secretary | Sell | 2,000.00 | 25.80 | 51,603.00 | 32,500.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm |
| 2019-04-18 | Benjamin L Palleiko | CBO, CFO and Secretary | Buy | 1,073.00 | 6.74 | 7,232.02 | 33,573.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm |
| 2019-04-22 | Benjamin L Palleiko | CBO, CFO and Secretary | Buy | 2,000.00 | 8.39 | 16,780.00 | 34,500.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009025/0001567619-19-009025-index.htm |
| 2019-04-10 | SVLSF IV, LLC | 10% Share Holder | Sell | 374.00 | 29.40 | 10,993.80 | 47,471.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm |
| 2019-04-09 | SVLSF IV, LLC | 10% Share Holder | Sell | 377.00 | 28.53 | 10,756.00 | 47,845.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm |
| 2019-04-08 | SVLSF IV, LLC | 10% Share Holder | Sell | 629.00 | 29.49 | 18,550.41 | 48,222.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319010492/0000899243-19-010492-index.htm |
| 2019-04-02 | SVLSF IV, LLC | 10% Share Holder | Sell | 253.00 | 28.76 | 7,277.24 | 48,851.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm |
| 2019-04-01 | SVLSF IV, LLC | 10% Share Holder | Sell | 1,458.00 | 27.66 | 40,325.66 | 49,104.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm |
| 2019-04-05 | Andreas Maetzel | Senior Vice President Medical | Buy | 5,000.00 | 7.91 | 39,550.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919008626/0001567619-19-008626-index.htm |
| 2019-03-29 | SVLSF IV, LLC | 10% Share Holder | Sell | 969.00 | 28.40 | 27,515.72 | 50,562.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009640/0000899243-19-009640-index.htm |
| 2019-03-28 | SVLSF IV, LLC | 10% Share Holder | Sell | 1,012.00 | 27.80 | 28,134.61 | 51,531.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm |
| 2019-03-27 | SVLSF IV, LLC | 10% Share Holder | Sell | 1,599.00 | 29.06 | 46,465.66 | 52,543.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm |
| 2019-03-26 | SVLSF IV, LLC | 10% Share Holder | Sell | 831.00 | 29.70 | 24,678.62 | 54,142.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319009178/0000899243-19-009178-index.htm |
| 2019-03-18 | SVLSF IV, LLC | 10% Share Holder | Sell | 7,246.00 | 26.70 | 193,468.20 | 54,973.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319008526/0000899243-19-008526-index.htm |
| 2019-03-05 | SVLSF IV, LLC | 10% Share Holder | Sell | 893.00 | 23.04 | 20,571.59 | 62,219.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm |
| 2020-10-29 | Christopher Yea | Chief Development Officer | Sell | 5,000.00 | 17.48 | 87,394.00 | 62,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120056468/0001209191-20-056468-index.htm |
| 2019-03-04 | SVLSF IV, LLC | 10% Share Holder | Sell | 1,197.00 | 22.91 | 27,419.68 | 63,112.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319006369/0000899243-19-006369-index.htm |
| 2019-02-21 | SVLSF IV, LLC | 10% Share Holder | Sell | 4,764.00 | 20.60 | 98,138.40 | 64,309.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm |
| 2020-10-21 | Christopher Yea | Chief Development Officer | Sell | 2,544.00 | 19.02 | 48,388.66 | 67,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm |
| 2019-02-20 | SVLSF IV, LLC | 10% Share Holder | Sell | 641.00 | 20.02 | 12,830.19 | 69,073.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm |
| 2019-02-19 | SVLSF IV, LLC | 10% Share Holder | Sell | 508.00 | 20.73 | 10,532.26 | 69,714.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319004359/0000899243-19-004359-index.htm |
| 2019-01-07 | SVLSF IV, LLC | 10% Share Holder | Sell | 72.00 | 20.41 | 1,469.66 | 70,222.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm |
| 2019-01-03 | SVLSF IV, LLC | 10% Share Holder | Sell | 47.00 | 20.01 | 940.61 | 70,294.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000686/0000899243-19-000686-index.htm |
| 2019-01-02 | SVLSF IV, LLC | 10% Share Holder | Sell | 6.00 | 20.00 | 120.00 | 70,341.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm |
| 2018-12-31 | SVLSF IV, LLC | 10% Share Holder | Sell | 702.00 | 20.00 | 14,042.81 | 70,347.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm |
| 2020-10-21 | Christopher Yea | Chief Development Officer | Sell | 3,500.00 | 17.68 | 61,892.95 | 70,513.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm |
| 2018-12-28 | SVLSF IV, LLC | 10% Share Holder | Sell | 103.00 | 20.03 | 2,062.78 | 71,049.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924319000172/0000899243-19-000172-index.htm |
| 2018-12-19 | SVLSF IV, LLC | 10% Share Holder | Sell | 59.00 | 20.02 | 1,181.06 | 71,152.00 | https://www.sec.gov/Archives/edgar/data/1348911/000089924318031591/0000899243-18-031591-index.htm |
| 2020-11-02 | Edward P. Feener | Chief Scientific Officer | Sell | 6,000.00 | 17.14 | 102,811.80 | 72,734.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120056919/0001209191-20-056919-index.htm |
| 2020-10-20 | Christopher Yea | Chief Development Officer | Sell | 2,302.00 | 18.01 | 41,466.62 | 74,013.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm |
| 2020-10-20 | Christopher Yea | Chief Development Officer | Sell | 5,640.00 | 17.27 | 97,419.16 | 76,315.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055590/0001209191-20-055590-index.htm |
| 2020-10-21 | Edward P. Feener | Chief Scientific Officer | Sell | 5,407.00 | 18.75 | 101,374.22 | 78,734.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm |
| 2020-10-16 | Christopher Yea | Chief Development Officer | Sell | 914.00 | 17.00 | 15,539.28 | 81,955.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055365/0001209191-20-055365-index.htm |
| 2020-02-05 | Christopher Yea | Chief Development Officer | Sell | 100.00 | 17.10 | 1,710.00 | 82,869.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761920002454/0001567619-20-002454-index.htm |
| 2019-01-22 | Christopher Yea | Chief Development Officer | Sell | 1,302.00 | 17.00 | 22,138.95 | 82,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm |
| 2019-01-23 | Christopher Yea | Chief Development Officer | Sell | 600.00 | 17.01 | 10,204.98 | 82,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm |
| 2019-01-25 | Christopher Yea | Chief Development Officer | Sell | 5,453.00 | 17.06 | 93,015.09 | 82,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001860/0001567619-19-001860-index.htm |
| 2019-04-22 | Christopher Yea | Chief Development Officer | Sell | 1,000.00 | 26.79 | 26,786.00 | 82,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009061/0001567619-19-009061-index.htm |
| 2019-07-22 | Christopher Yea | Chief Development Officer | Sell | 7,355.00 | 18.35 | 134,929.68 | 82,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015142/0001567619-19-015142-index.htm |
| 2019-12-12 | Christopher Yea | Chief Development Officer | Sell | 199.00 | 17.00 | 3,383.00 | 82,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm |
| 2019-12-13 | Christopher Yea | Chief Development Officer | Sell | 1,500.00 | 17.05 | 25,567.95 | 82,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm |
| 2019-12-16 | Christopher Yea | Chief Development Officer | Sell | 3,010.00 | 17.05 | 51,318.39 | 82,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm |
| 2019-12-20 | Christopher Yea | Chief Development Officer | Sell | 2,646.00 | 17.02 | 45,025.13 | 82,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023612/0001567619-19-023612-index.htm |
| 2019-12-12 | Christopher Yea | Chief Development Officer | Buy | 199.00 | 0.00 | 0.86 | 83,168.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm |
| 2019-01-23 | Christopher Yea | Chief Development Officer | Buy | 600.00 | 0.00 | 2.58 | 83,569.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm |
| 2019-04-22 | Christopher Yea | Chief Development Officer | Sell | 6,355.00 | 25.92 | 164,743.84 | 83,969.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009061/0001567619-19-009061-index.htm |
| 2020-10-21 | Edward P. Feener | Chief Scientific Officer | Sell | 3,600.00 | 17.65 | 63,554.04 | 84,141.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm |
| 2019-01-22 | Christopher Yea | Chief Development Officer | Buy | 1,302.00 | 0.00 | 5.60 | 84,271.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001609/0001567619-19-001609-index.htm |
| 2019-12-13 | Christopher Yea | Chief Development Officer | Buy | 1,500.00 | 0.00 | 6.45 | 84,469.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm |
| 2019-12-20 | Christopher Yea | Chief Development Officer | Buy | 2,646.00 | 0.00 | 11.38 | 85,615.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023612/0001567619-19-023612-index.htm |
| 2019-12-16 | Christopher Yea | Chief Development Officer | Buy | 3,010.00 | 0.00 | 12.94 | 85,979.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919023163/0001567619-19-023163-index.htm |
| 2020-10-20 | Edward P. Feener | Chief Scientific Officer | Sell | 2,300.00 | 18.00 | 41,406.90 | 87,741.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm |
| 2019-01-25 | Christopher Yea | Chief Development Officer | Buy | 5,453.00 | 0.00 | 23.45 | 88,422.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919001860/0001567619-19-001860-index.htm |
| 2020-10-20 | Edward P. Feener | Chief Scientific Officer | Sell | 5,600.00 | 17.26 | 96,683.44 | 90,041.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055589/0001209191-20-055589-index.htm |
| 2019-04-22 | Christopher Yea | Chief Development Officer | Buy | 7,355.00 | 0.00 | 31.63 | 90,324.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919009061/0001567619-19-009061-index.htm |
| 2019-07-22 | Christopher Yea | Chief Development Officer | Buy | 7,355.00 | 0.00 | 31.63 | 90,324.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015142/0001567619-19-015142-index.htm |
| 2019-07-17 | Albert Cha | Director | Buy | 1,060.00 | 16.97 | 17,990.96 | 926,141.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm |
| 2020-10-16 | Edward P. Feener | Chief Scientific Officer | Sell | 993.00 | 17.00 | 16,881.00 | 95,641.00 | https://www.sec.gov/Archives/edgar/data/1348911/000120919120055363/0001209191-20-055363-index.htm |
| 2020-02-05 | Edward P. Feener | Chief Scientific Officer | Sell | 100.00 | 17.11 | 1,711.00 | 96,634.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761920002453/0001567619-20-002453-index.htm |
| 2019-07-23 | Edward P. Feener | Chief Scientific Officer | Sell | 1,900.00 | 18.65 | 35,438.99 | 96,734.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015141/0001567619-19-015141-index.htm |
| 2019-07-19 | Albert Cha | Director | Buy | 49,680.00 | 17.84 | 886,127.26 | 975,821.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015022/0001567619-19-015022-index.htm |
| 2019-07-22 | Edward P. Feener | Chief Scientific Officer | Sell | 1,400.00 | 18.57 | 26,004.02 | 98,634.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015141/0001567619-19-015141-index.htm |
| 2019-07-26 | Albert Cha | Director | Buy | 21,942.00 | 16.83 | 369,316.77 | 997,763.00 | https://www.sec.gov/Archives/edgar/data/1348911/000156761919015484/0001567619-19-015484-index.htm |